The Clinical journal of pain
-
Randomized Controlled Trial Multicenter Study
Sebacoyl Dinalbuphine Ester Extended-Release Injection for Long- Acting Analgesia: A Multicenter, Randomized, Double Blind, And Placebo-controlled study in Hemorrhoidectomy Patients.
This study was conducted to evaluate the safety and efficacy of single sebacoyl dinalbuphine ester (SDE) injection (150 mg/2 mL) when administered intramuscularly to patients who underwent hemorrhoidectomy for postoperative long-acting analgesia. ⋯ SDE injection demonstrated an extended analgesia effect, with a statistically significant reduction in pain intensity through 48 hours and 7 days after hemorrhoidectomy.